Background {#Sec1}
==========

The benefits of off-pump coronary artery bypass grafting (CABG) in low risk patients remains debatable and still unknown since very large randomized trials would be required to show a difference in stroke and mortality when compared to on-pump CABG. Nevertheless, there are numerous studies that show benefits with the off-pump revascularization in low as well as high risk patients \[[@CR1]--[@CR5]\]. The former showed shorter intensive care unit (ICU) and hospital stay, shorter ventilation time, decreased rate of atrial fibrillation, transfusion, inotrope requirements, respiratory infections, stroke, delirium, and postoperative MI \[[@CR1]\]. Other studies reported that the off-pump CABG has no advantages or even disadvantages over on-pump, such as equal mortality, myocardial infarction, stroke, equal or lower long-term graft patency \[[@CR6]--[@CR9]\].

The purpose of the present study was to compare short-term outcomes (mortality and complications) for all consecutive patients undergoing CABG surgery at our Veterans Affairs (VA) center from 2007 to 2012. Over this five year period, we have used a selective approach in directing higher risk patients towards off-pump coronary artery bypass surgery with the aim of improving overall outcomes.

Methods {#Sec2}
=======

We retrospectively studied patients that underwent a CABG procedure at our VA Hospital, between October 2007, and December 2012. A strategy to assign higher risk patients for off-pump revascularization was employed, while lower risk patients were randomly assigned to receive CABG either on pump or off-pump. The procedures were performed by two experienced surgeons who performed the procedure either 100 % off-pump or on-pump, respectively. There were no patient exclusions. In this study, labeling a patient at higher postoperative risk was a clinical decision made by the surgical team when one or more co-morbidities perceived to increase the risk of postoperative complications were identified during standard preoperative work-up. Proximal anastomoses were performed using a no-clamp technique for the aorta employing an anastomotic enabling device (HEARTSTRING System: MAQUET, San Jose, CA, USA) in 100 % of cases. Short-term clinical outcomes including 30-days operative mortality and perioperative morbidity were evaluated. The 30-day operative mortality was defined as any death occurring during the index hospitalization or within 30 days after surgery. The perioperative morbidity was defined as the presence or absence of any of the following major complications: cardiac arrest, renal failure requiring dialysis, stroke (acute loss of focal neurological function lasting \>72 hours with our without permanent neurological deficit), coma, and repeat cardiac surgery, reoperation for bleeding, new mechanical support, mediastinitis and tracheostomy during the inpatient perioperative period or within 30 days after surgery.

Statistical analysis {#Sec3}
--------------------

Continuous variables are presented as mean ± standard deviation, and categorical variables are represented as number and percentage. When the distribution appeared to be skewed we produced median and interquartile ranges (IQ) ranges and compared using the Mann-Whitney U-test. Continuous variables were compared using t-test. Categorical variables were compared using the chi-square test. *P*-values less than 0.05 (two-sided) were considered statistically significant. All analyses were performed using the IBM SPSS statistical software program (IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp).

Results {#Sec4}
=======

Demographic profiles {#Sec5}
--------------------

Two hundred fifty two patients underwent a CABG procedure from 10/2007 through 12/2012. One hundred seventy (67 %) of those procedures were performed off-pump and 82 (33 %) were performed on-pump. Patient demographics and preoperative characteristics are shown in Table [1](#Tab1){ref-type="table"}. Mean age for both off- and on-pump CABG patients was similar (*p* = 0.84). The majority of the patients in both groups were males with a mean BMI of 31 kg/m^2^. All of the cases were performed as elective procedures and none of the patients had a previous cardiac surgery. There were significantly more patients that were active smokers (*p* = 0.002), with low LVEF (\<45 %; *p* = 0.008) and cerebrovascular disease (CVD; *p* = 0.024) in the off-pump CABG *vs*. on-pump CABG groups (Table [1](#Tab1){ref-type="table"}). The number of patients with COPD, diabetes, hypertension or peripheral vascular disease was similar in both groups (Table [1](#Tab1){ref-type="table"}).Table 1Pre-operative patient backgroundOff-pump (*n* = 170)On-pump (*n* = 82)*p*-valueDemographics Age (years)64 ± 965 ± 80.84 Gender (male)169 (99 %)80 (98 %)0.51 BMI (kg/m^2^)31 ± 631 ± 60.81 Urgent Status18 (11 %)15 (18 %)0.12 Previous heart surgery00 Current smoker48 (28 %)9 (11 %)0.002\*Comorbidities COPD43 (25 %)14 (17 %)0.15 PVD26 (15 %)8 (10 %)0.27 DM70 (41 %)38 (46 %)0.45 HTN161 (95 %)74 (90 %)0.13 CVD48 (28 %)12 (15 %)0.024\*Cardiac function LVEF \< 45 %47 (28 %)11 (13 %)0.008\*Values are n (%) or mean ± SD. \*Statistically significant associations (*p* \< 0.05). *BMI* body mass index; *COPD* chronic pulmonary obstructive disease; *PVD* peripheral vascular disease; *DM* diabetes mellitus; *HTN* hypertension; *LVEF* left ventricular ejection fraction; *CVD* cerebrovascular disease

Post-operative outcomes and complications {#Sec6}
-----------------------------------------

Both off-pump and on-pump patients had similar number of grafts (3 ± 1; *p* = 0.99). None of the patients who underwent off-pump CABG were converted to on-pump during surgery (Table [2](#Tab2){ref-type="table"}). While the off-pump CABG patients had a higher ventilation time (7.4 ± 1.1 *vs*. 6.5 ± 0.1; *p* \< 0.001), intensive care unit (ICU) and hospital length of stay was similar in both groups (Table [2](#Tab2){ref-type="table"}). None of the off-pump patients had a stroke or coma (Table [3](#Tab3){ref-type="table"}). Off-pump CABG patients had a significant lower 30-day composite risk of morbidity and mortality (*p* = 0.019). Other short-term end points such as, 30-day mortality, the number of bypass grafts, rate of infections or reoperations for bleeding were not significant between the 2 groups (Table [3](#Tab3){ref-type="table"}). In this study NMS consisted of new IABP only, no patients required ECMO or VAD support.Table 2Clinical OutcomesOff Pump (*n* = 170)On-Pump (*n* = 82)*p*-valueNumber of grafts3 ± 13 ± 10.99Conversion to On-pump0NAVentilation time (h)7.4 ± 1.16.5 ± 0.1\<0.001\*Length of ICU stay (d)2.9 ± 2.02.4 ± 2.50.10Length of hospital stay (d)9.8 ± 6.58.5 ± 5.00.08Values are mean ± SD. \*Statistically significant associations (*p* \< 0.05). *ICU* intensive care unitTable 3Post-operative complicationsAll patients (*n* = 252)Off-Pump (*n* = 170)On-pump (*n* = 82)*P*-value30-day composite15 (6 %)6 (3.5 %)9 (11 %)0.019\*30-day mortality5 (1.9 %)3 (1.7 %)2 (2.4 %)0.70Cardiac arrest1 (0.4 %)1 (0.6 %)00.49Renal failure requiring dialysis1 (0.4 %)1 (0.6 %)00.49Stroke2 (0.8 %)02 (2.4 %)0.044\*Coma1 (0.4 %)01 (1.2 %)0.15Bleeding requiring reoperation2 (0.8 %)1 (0.6 %)1 (1.2 %)0.60Tracheostomy1 (0.4 %)1 (0.6 %)00.49Mediastinitis6 (2.4 %)6 (3.5 %)00.088New mechanical support3 (1 %)03 (3.6 %)0.013\*30-day Composite -- Death, Reoperation, New mechanical support, Cardiac arrest, Coma, Stroke, or Renal failure

Discussion {#Sec7}
==========

Using a selective strategy to assign higher risk patients for off-pump revascularization, the veterans who received CABG (either on- or off-pump) at our VA Medical Center had a 6 % 30-day composite rate of morbidity and mortality. Cornwell et al \[[@CR10]\] reported a 30-day composite rate of 10.5 % in 31942 veterans who underwent CABG between 2004 and 2011 at 42 VA cardiac surgery centers that participate in VASQIP data base.

The ROOBY trial \[[@CR11]\] reviewed and compared the short-term and 1-year composite outcomes of patients who received off-pump or on-pump CABG from 18 VA medical centers. There was no significant difference between off-pump CABG and on-pump CABG in the rate of 30-day composite outcome and the rate of 1-year composite outcome was even higher for off-pump CABG than on-pump CABG. The long-term grafts patency was lower and more patients received fewer grafts than originally planned in off-pump CABG in this trial and there were no treatment-based differences in neuropsychological outcomes or short-term use of major resources. ROOBY trial concluded that off-pump CABG offered no benefit over on-pump CABG and resulted in worse composite morbidity and mortality outcomes. We believe the high conversion rates (12 %) in the ROOBY trial \[[@CR11]\] and other trials (7.9 % in CORONARY \[[@CR12]\] and 5 % in GOPCABE \[[@CR13]\] may explain the inferior outcomes with off-pump revascularization in those studies.

When compared with off-pump patients in the ROOBY trial our off-pump CABG patients had lower rates in terms of 30-day composite outcome (7 % vs. 3.5 %), cardiac arrest (1.8 % vs. 0.6 %), stroke (1.3 % vs. 0 %) and reoperation for bleeding (2.7 % vs. 0.6 %). Those patients also had no conversions to on-pump CABG, shorter postoperative stay in the ICU, and shorter total hours on ventilator when compared with patients undergoing off-pump revascularization included in the ROOBY trial \[[@CR11]\].

The main limitations of our study include its retrospective nonrandomized design, analysis of limited number of patients from a single institution and the majority of patients being male data because of the nature of the veteran population.

Conclusions {#Sec8}
===========

In conclusion, our strategy to preferentially assign all veterans in need of elective CABG but perceived to have higher risk of perioperative complications for off-pump revascularization resulted in a lower 30-day composite morbidity and mortality in veterans who received CABG at our medical center over a five year period compared to the national average over a similar period of time \[[@CR10]\]. Despite having higher prevalence of lower EF, CVD and smoking, veterans who underwent off-pump revascularization had lower short-term composite complication rate than those who underwent on-pump revascularization as well. Higher risk VA patients may benefit from an off-pump approach when CABG is indicated.
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